Short Interest in Merck & Co., Inc. (NYSE:MRK) Decreases By 14.6% - MarketBeat
Short Interest in Merck & Co., Inc. (NYSE:MRK) Decreases By 14.6% MarketBeat
Merck & Co Company News
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline - BioSpace
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline BioSpace
Merck & Co., Inc. $MRK Shares Purchased by NEOS Investment Management LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by NEOS Investment Management LLC MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Tobam - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Tobam MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Fifth Third Bancorp - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Fifth Third Bancorp MarketBeat
Mondrian Investment Partners LTD Invests $138.34 Million in Merck & Co., Inc. $MRK - MarketBeat
Mondrian Investment Partners LTD Invests $138.34 Million in Merck & Co., Inc. $MRK MarketBeat
PNC Financial Services Group Inc. Purchases 144,703 Shares of Merck & Co., Inc. $MRK - MarketBeat
PNC Financial Services Group Inc. Purchases 144,703 Shares of Merck & Co., Inc. $MRK MarketBeat
GSA Capital Partners LLP Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
GSA Capital Partners LLP Raises Stock Holdings in Merck & Co., Inc. $MRK MarketBeat
Merit Financial Group LLC Purchases 16,545 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merit Financial Group LLC Purchases 16,545 Shares of Merck & Co., Inc. $MRK MarketBeat
Aberdeen Group plc Sells 46,708 Shares of Merck & Co., Inc. $MRK - MarketBeat
Aberdeen Group plc Sells 46,708 Shares of Merck & Co., Inc. $MRK MarketBeat
Texas Yale Capital Corp. Has $4.83 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Texas Yale Capital Corp. Has $4.83 Million Stake in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Stake Lessened by Skandinaviska Enskilda Banken AB publ - MarketBeat
Merck & Co., Inc. $MRK Stake Lessened by Skandinaviska Enskilda Banken AB publ MarketBeat
Vanguard Group Inc. Sells 777,516 Shares of Merck & Co., Inc. $MRK - MarketBeat
Vanguard Group Inc. Sells 777,516 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Calton & Associates Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Calton & Associates Inc. MarketBeat
Pallas Capital Advisors LLC Grows Stake in Merck & Co., Inc. $MRK - MarketBeat
Pallas Capital Advisors LLC Grows Stake in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Public Sector Pension Investment Board - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Public Sector Pension Investment Board MarketBeat
Merck & Co., Inc. $MRK Shares Sold by ABN Amro Investment Solutions - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by ABN Amro Investment Solutions MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Shell Asset Management Co. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Shell Asset Management Co. MarketBeat
Ameritas Advisory Services LLC Has $1.16 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Ameritas Advisory Services LLC Has $1.16 Million Holdings in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. (NYSE:MRK) Upgraded to Buy at Deutsche Bank Aktiengesellschaft - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Upgraded to Buy at Deutsche Bank Aktiengesellschaft MarketBeat
Merck's 2026 outlook clouds upbeat fourth-quarter results - Reuters
Merck's 2026 outlook clouds upbeat fourth-quarter results Reuters
Mraz Amerine & Associates Inc. Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Mraz Amerine & Associates Inc. Grows Stock Position in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Savvy Advisors Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Savvy Advisors Inc. MarketBeat
Krilogy Financial LLC Buys 21,122 Shares of Merck & Co., Inc. $MRK - MarketBeat
Krilogy Financial LLC Buys 21,122 Shares of Merck & Co., Inc. $MRK MarketBeat
Atria Investments Inc Has $15.08 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Atria Investments Inc Has $15.08 Million Stock Position in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Varma Mutual Pension Insurance Co - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Varma Mutual Pension Insurance Co MarketBeat
ABC Arbitrage SA Buys Shares of 11,779 Merck & Co., Inc. $MRK - MarketBeat
ABC Arbitrage SA Buys Shares of 11,779 Merck & Co., Inc. $MRK MarketBeat
LSV Asset Management Has $444.77 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
LSV Asset Management Has $444.77 Million Stock Position in Merck & Co., Inc. $MRK MarketBeat
Merck Vaccine Sales Drop as US Declines Strike Another Pharma - BioSpace
Merck Vaccine Sales Drop as US Declines Strike Another Pharma BioSpace
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline - Business Wire
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline Business Wire
Germany's Merck eyes life science deals, but muted 2026 outlook knocks shares - Reuters
Germany's Merck eyes life science deals, but muted 2026 outlook knocks shares Reuters
Merck to invest $3 billion in Elkton expansion, adding up to 500 jobs in Shenandoah Valley - Virginia Mercury
Merck to invest $3 billion in Elkton expansion, adding up to 500 jobs in Shenandoah Valley Virginia Mercury
Merck no longer in talks to buy Revolution Medicines, WSJ reports - Reuters
Merck no longer in talks to buy Revolution Medicines, WSJ reports Reuters
Merck scraps £1bn expansion in the UK over lack of state investment - BBC
Merck scraps £1bn expansion in the UK over lack of state investment BBC
Merck plans spending shift to boost business beyond Keytruda - BioPharma Dive
Merck plans spending shift to boost business beyond Keytruda BioPharma Dive
How To Win Deals In A Competitive Market, With Merck & Co. BD Exec Elizabeth Naldi-Jacob - Citeline News & Insights
How To Win Deals In A Competitive Market, With Merck & Co. BD Exec Elizabeth Naldi-Jacob Citeline News & Insights
Merck & Co. targets $3B in cost savings, including from job cuts - FirstWord Pharma
Merck & Co. targets $3B in cost savings, including from job cuts FirstWord Pharma
Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook - CNBC
Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook CNBC
Merck & Co to cut 6000 jobs, Moderna to cut around 500 - Chemistry World
Merck & Co to cut 6000 jobs, Moderna to cut around 500 Chemistry World
Merck executes its own Brexit, moving all R&D operations out of UK - Fierce Biotech
Merck executes its own Brexit, moving all R&D operations out of UK Fierce Biotech